Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
BCYC compared with VYGR: revenue, margins and what each company keeps, and the suppliers and customers both name
BCYC
Bicycle Therapeutics PLC
Change
Mkt cap
Revenue
Revenue
VYGR
Voyager Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
BCYC
Bicycle Therapeutics PLC
vs
VYGR
Voyager Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
BCYC, solid
VYGR, dashed
Supply-chain overlap
Revenue flow
BCYC: latest quarter is a loss; flow not drawable. VYGR: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only BCYC
2
—
Eckert & Ziegler Strahlen- und Medizintechnik
unlisted
supplier
—
Bayer Consumer Care
unlisted
customer
Shared
0
No shared counterparties.
Only VYGR
2
NBIX
Neurocrine Biosciences
customer
NVS
Novartis Pharma
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
BCYC
Bicycle Therapeutics PLC
Change
3.65
▼
−4.34%
· post 3.65
Mkt cap
$256.5M
Revenue
$34M
Q3 FY26
Revenue
$73M
FY25
VYGR
Voyager Therapeutics, Inc.
Change
1.72
▼
−2.52%
· post 1.72
Closed
Oct 30 '26
Mkt cap
$106.0M
Revenue
$3M
Q2 FY26
Revenue
$40M
FY25
vs
Compare
Closed
Oct 30 '26
BCYC
Bicycle Therapeutics PLC
vs
VYGR
Voyager Therapeutics, Inc.
3.65
▼
−4.34%
post 3.65
Price
1.72
▼
−2.52%
post 1.72
$256.5M
Mkt cap
$106.0M
Q3 FY26
$34M
Revenue
$3M
Q2 FY26
FY25
$73M
Revenue
$40M
FY25
Change
Change
BCYC
3.65
▼
−4.34%
vs
VYGR
1.72
▼
−2.52%
Closed
Oct 30 '26